Bringing the fundamentals into focus…
Back to Ginkgo Bioworks Holdings, Inc.
How Ginkgo Bioworks Holdings, Inc. stacks up
DNA · against 436 other Healthcare companies of similar size
Growth
2/ 100
Near the bottom of its peers.
Ranked #423 of 437 · scores higher than 1% of peers
Bars: peers in each 10-point band of the growth score48 peers with a growth score of 0–9, including DNA · Click a bar to see the companies
Why growth scores 2?
Weighted metrics compared with all Healthcare companies.Mainly because of its earnings per share growth, 3-year revenue growth and revenue growth, which are weaker than most Healthcare peers.
- slower growth in earnings per share: weaker than 99% of peers. Earnings per share growth: -91.9% vs peer median 9.8%
- slower revenue growth over three years: weaker than 95% of peers. 3-year revenue growth: -25.9% vs peer median 5.8%
- slower revenue growth over the last year: weaker than 95% of peers. Revenue growth: -37.0% vs peer median 6.1%
Metric by metric
Position: dot = DNA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | DNA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 448 reported | -37.0% | 3.4% | 5% | 33% | |
| Earnings per share growthHigher is better · 238 reported | -91.9% | 3.9% | 1% | 33% | |
| 3-year revenue growthHigher is better · 430 reported | -25.9% | 4.5% | 5% | 33% |
Ranking by growth score
Top 5 and the companies ranked around DNA| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 885M USD | 99 | 33 | |
| 423 | 5.1B CNY (≈$709M) | 2 | 12 | |
| 423 | 9.1B CNY (≈$1.3B) | 2 | 20 | |
| 423 | 7.5B CNY (≈$1.1B) | 2 | 26 | |
| 423 | 4.0B CNY (≈$563M) | 2 | 18 | |
| 423 | 725M USD | 2 | 19 | |
| 423 | 366M CHF (≈$421M) | 2 | 23 | |
| 423 | 1.3B USD | 2 | 27 | |
| 432 | 3.4B CNY (≈$482M) | 1 | 22 | |
| 433 | 4.6B CNY (≈$645M) | 0 | 17 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score